CoChat

Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces.

Ferreira, Viviana P, Herbert, Andrew P, Hocking, Henry G, Barlow, Paul N, Pangburn, Michael K · 2006 · The Journal of Immunology
Cited by 131

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

The plasma protein factor H primarily controls the activation of the alternative pathway of complement. The C-terminal of factor H is known to be involved in protection of host cells from complement attack. In the present study, we show that domains 19–20 alone are capable of discriminating between host-like and complement-activating cells. Furthermore, although factor H possesses three binding sites for C3b, binding to cell-bound C3b can be almost completely inhibited by the single site located in domains 19–20. All of the regulatory activities of factor H are expressed by the N-terminal four domains, but these activities toward cell-bound C3b are inhibited by isolated recombinant domains 19–20 (rH 19–20). Direct competition with the N-terminal site is unlikely to explain this because regulation of fluid phase C3b is unaffected by domains 19–20. Finally, we show that addition of isolated rH 19–20 to normal human serum leads to aggressive complement-mediated lysis of normally nonactivating sheep erythrocytes and moderate lysis of human erythrocytes, which possess membrane-bound regulators of complement. Taken together, the results highlight the importance of the cell surface protective functions exhibited by factor H compared with other complement regulatory proteins. The results may also explain why atypical hemolytic uremic syndrome patients with mutations affecting domains 19–20 can maintain complement homeostasis in plasma while their complement system attacks erythrocytes, platelets, endothelial cells, and kidney tissue.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.177.9.6308

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 70

  1. 2001, J. Am. Soc. Nephrol., 297
  2. 2000, Am. J. Hum. Genet., 1721
  3. 2004, J. Am. Soc. Nephrol., 787
  4. 2003, J. Clin. Invest., 1181
  5. 1994, Am. J. Kidney Dis., 936
  6. 2001, Am. J. Hum. Genet., 485
  7. 2004, Mol. Immunol., 355
  8. 1998, Kidney Int., 836
  9. 1999, Am. J. Hum. Genet., 1538
  10. 1999, Mol. Immunol., 241
  11. 2006, Hum. Mutat., 292
  12. 2005, Ann. NY Acad. Sci., 144
  13. 2005, Hum. Mol. Genet., 703
  14. 2001, Am. J. Hum. Genet., 478
  15. 2002, J. Mol. Biol., 217
  16. 2006, J. Biol. Chem., 16512
  17. 2006, EMBO J., 1784
  18. 2005, Am. J. Pathol., 1173
  19. 2002, Nat. Genet., 424
  20. 2000, J. Immunol., 6075
  21. 2002, Br. J. Cancer, 1119
  22. 1998, J. Immunol., 3342
  23. 1987, Infect. Immun., 174
  24. 2005, J. Infect. Dis., 1996
  25. 1998, J. Exp. Med., 743
  26. 1992, FEMS Microb. Lett., 287
  27. 1992, Infect. Immun., 39
  28. 1995, J. Clin. Invest., 1054
  29. 1986, Proc. Natl. Acad. Sci. USA, 3963
  30. 1988, Biochem. J., 593
  31. 1992, J. Immunol., 2592
  32. 1989, J. Biol. Chem., 20576
  33. 1984, Biochem. J., 389
  34. 1996, J. Immunol., 5422
  35. 1995, J. Immunol., 348
  36. 1995, J. Immunol., 5663
  37. 1990, Proc. Natl. Acad. Sci. USA, 3982
  38. 2006, Mol. Immunol., 1624
  39. 1991, J. Biol. Chem., 16847
  40. 1996, Proc. Natl. Acad. Sci. USA, 10996
  41. 1996, FEBS Lett., 297
  42. 2000, J. Biol. Chem., 27657
  43. 2004, Mol. Immunol., 291
  44. 1996, Eur. J. Immunol., 2383
  45. 1977, J. Exp. Med., 257
  46. 1998, Biochem. J., 41
  47. 1978, Proc. Natl. Acad. Sci. USA, 1971
  48. 1978, Proc. Natl. Acad. Sci. USA, 2416
  49. 2005, Science, 421
  50. 2005, Science, 419
  51. 2005, Science, 385
  52. 2005, Proc. Natl. Acad. Sci. USA, 7227
  53. 1981, J. Biol. Chem., 3995
  54. 1987, J. Immunol. Methods, 7
  55. 1971, J. Exp. Med., 90s
  56. 1979, J. Immunol., 529
  57. 1983, Methods Enzymol., 278
  58. 1998, J. Biol. Chem., 16828
  59. 1982, J. Immunol., 2603
  60. 1983, Proc. Natl. Acad. Sci. USA, 5430
  61. 1977, J. Exp. Med., 22
  62. 2000, J. Immunol., 4742
  63. 1991, Transfus. Med. Rev., 123
  64. 1998, Complement Regulatory Proteins, 32
  65. 2000, J. Biol. Chem., 12917
  66. 2005, Clin. Chem., 856
  67. 1987, Mol. Immunol., 487
  68. 2006, Clin. Exp. Immunol., 342
  69. 2001, Kidney Int., 831
  70. 2006, J. Mol. Med., 378

Cited by

See all 131

Metadata

Authors
Ferreira, V. P., Herbert, A. P., Hocking, H. G., Barlow, P. N., & Pangburn, M. K.
Affiliations
  • Department of Biochemistry, Center for Biomedical Research, University of Texas, Health Science Center , Tyler, TX 75708
  • Edinburgh Biomolecular Nuclear Magnetic Resonance Unit, University of Edinburgh , Edinburgh ,
Venue
The Journal of Immunology
Published
2006-11-01
Volume
177
Issue
9
Pages
6308-6316
ISSN
  • 0022-1767
  • 1550-6606
Cited by
131
References
4
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces. https://app.cochat.ai/papers/10.4049/jimmunol.177.9.6308
The paper
Ferreira, V. P., Herbert, A. P., Hocking, H. G., Barlow, P. N., & Pangburn, M. K. (2006). Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces. The Journal of Immunology. https://doi.org/10.4049/jimmunol.177.9.6308

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.